These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Measurement of antibodies to Herpesvirus hominis by indirect immunofluorescent antibody method. Cho CT; Feng KK; Liu C Microsc Acta; 1977 Jan; 79(1):47-54. PubMed ID: 190522 [TBL] [Abstract][Full Text] [Related]
27. [Herpes simplex virus and Guillain-Barré syndrome in a child]. Gedalia A; Sarov I Harefuah; 1987 Feb; 112(3):125-7. PubMed ID: 3038712 [No Abstract] [Full Text] [Related]
28. Evaluation of indirect hemagglutination and its inhibition in the differentiation between antibodies to herpes simplex virus types 1 and 2 for seroepidemiologic studies: use of a II/I index threshold of 85 and an assay of type-specific antibodies. Prakash SS; Seth P J Infect Dis; 1979 May; 139(5):524-8. PubMed ID: 220339 [TBL] [Abstract][Full Text] [Related]
30. Fluorescence and neutralizing antibodies to herpes simplex virus in the cerebrospinal fluid of patients with central nervous system diseases. Leventon-Kriss S; Rannon L; Joffe R Isr J Med Sci; 1976 Jun; 12(6):553-9. PubMed ID: 182656 [TBL] [Abstract][Full Text] [Related]
31. [Seroepidemiological studies for the detection of Cytomegalovirus (CMV) and herpes simplex virus (HSV) infections among girls and women in Poland]. Imbs D; Rudnicka H Przegl Epidemiol; 1987; 41(3):286-94. PubMed ID: 2829284 [No Abstract] [Full Text] [Related]
32. Inhibition of herpes simplex virus type 1 (HSV-1) plaque enlargement by neutralizing sera. Mannini-Palenzona A; Costanzo F; Foà-Tomasi L; Negosanti M; Lanzoni A Microbiologica; 1989 Jul; 12(3):231-40. PubMed ID: 2476650 [TBL] [Abstract][Full Text] [Related]
34. Incidence of Herpesvirus hominis antibodies among blood donor populations. Roome AP; Montefiore D; Waller D Br J Vener Dis; 1975 Oct; 51(5):324-8. PubMed ID: 172191 [TBL] [Abstract][Full Text] [Related]
35. A review of the identification and titration of antibodies to herpes simplex viruses type 1 and type 2 in human sera. Plummer G Cancer Res; 1973 Jun; 33(6):1469-76. PubMed ID: 4352384 [No Abstract] [Full Text] [Related]
36. [Studies on complement fixation viral antibody. In reference to frequencies of various antibodies and patients with sudden deafness]. Takamiya H; Oshikawa T; Kuroki S; Ohtani H; Saito M; Okamoto M; Fujino A; Shitara T Rinsho Byori; 1984 Dec; 32(12):1355-60. PubMed ID: 6099436 [No Abstract] [Full Text] [Related]
37. Distribution of complement-requiring neutralizing antibody against herpes simplex virus in human population. Kawana R; Sato H; Sato N Jpn J Microbiol; 1972 Sep; 16(5):447-9. PubMed ID: 4345979 [No Abstract] [Full Text] [Related]
38. Experimental herpes simplex virus type 1 encephalitis: ratios of serum- to cerebrospinal fluid-antibody titers and their relation to fever and virus activity. Levine DP; Lerner AM J Infect Dis; 1984 Jun; 149(6):1025. PubMed ID: 6330234 [No Abstract] [Full Text] [Related]
39. Lymphocyte interferon production and transformation after Herpes simplex infections in humans. Rasmussen LE; Jordan GW; Stevens DA; Merigan TC J Immunol; 1974 Feb; 112(2):728-36. PubMed ID: 4360547 [No Abstract] [Full Text] [Related]
40. Serological evidence of herpes simplex virus infection in atopic eczema. David TJ; Richmond SJ; Bailey AS Arch Dis Child; 1987 Apr; 62(4):416-7. PubMed ID: 3036021 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]